-
By Tom Murphy |
May 2, 2012
CVS Caremark Corp. gained millions of new prescriptions in the first quarter due to a contract impasse between two rivals, and now the drugstore chain wants to keep the growth going by ensuring that those customers stick around and use the rest of its store.
-
April 3, 2012
A Goldman Sachs analyst said Tuesday that Express Scripts Holding Co. is poised for strong profit growth for the rest of this decade after the pharmacy benefits manager completed its acquisition of former competitor Medco Health Solutions.
-
By Tom Murphy |
March 27, 2012
Walgreen Co.'s fiscal second-quarter earnings fell almost 8 percent, knocked down largely by its exit from the Express Scripts pharmacy network, but the drugstore operator still topped analyst expectations, and its shares outperformed broader market indexes Tuesday.
-
By Judy Lin |
March 26, 2012
Medco has agreed to pay $2.7 million to settle an investigation into influence-peddling at California's largest public pension fund.
-
By The Associated Press |
March 13, 2012
Shares of drugstore operator and pharmacy benefits manager CVS Caremark Corp. are approaching their full value according to a BMO Capital analyst who lowered his rating on the stock to "market perform" from "outperform."
-
By The Associated Press |
February 22, 2012
Walgreen Co. and some independent drugstores are investing in a nationwide push to give pharmacists a chance to work more with patients to improve care and cut costs.
-
By Tom Murphy |
February 8, 2012
CVS Caremark Corp.'s fourth-quarter earnings climbed nearly 4 percent as the drugstore operator's pharmacy services revenue swelled because of a long-term contract and new business.
-
By AP Staff Writer |
February 7, 2012
Citi Investment Research analysts said Tuesday that CVS Caremark Corp. and some smaller pharmacy benefits management companies should benefit in 2012 and 2013 from the split between Walgreen Co. and leading PBM Express Scripts Inc.
-
January 12, 2012
CVS Caremark says it will pay $5 million to resolve allegations that one of its subsidiaries understated the price of several drugs on a Medicare website.
-
January 9, 2012
Health Net Inc. said Monday it will sell its Medicare Part D stand-alone prescription drug business to CVS Caremark for $160 million.